Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

HDMA Shifts Focus To Government Affairs; CEO Streck Expected To Leave

  • News

Executive Summary

The Healthcare Distribution Management Association will focus more on legislative affairs upon completion of a leadership transition

You may also be interested in...



HDMA Interim Head Is COO Hanagan; CEO Streck Retiring Dec. 31

The Healthcare Distribution Management Association has named Chief Operating Officer Nancy Hanagan to serve as interim CEO while the association searches for a successor to Ron Streck

HDMA Interim Head Is COO Hanagan; CEO Streck Retiring Dec. 31

The Healthcare Distribution Management Association has named Chief Operating Officer Nancy Hanagan to serve as interim CEO while the association searches for a successor to Ron Streck

McKesson Sees Cash Flow Upside To Slow Growth, Inventory Management

McKesson sees a bright spot from the overall slowdown in the pharmaceutical market and the prevalence of inventory management arrangements: enhanced cash flow

Table

View full table

Tags:
Latest Headlines

Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director

Puberty Blockers: FDA's Califf Asked If REMS, Boxed Warning Against Off-Label Use In The Works

ADHD Drugs: FDA Commissioner Blames Inappropriate Prescribing For Shortages

Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug

See All
UsernamePublicRestriction

Register

PS042498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By